KR20170100369A - Composition comprising nelumbo nucifera gaertner extract for anti-oxidant and anti-bacterial effect - Google Patents
Composition comprising nelumbo nucifera gaertner extract for anti-oxidant and anti-bacterial effect Download PDFInfo
- Publication number
- KR20170100369A KR20170100369A KR1020160022851A KR20160022851A KR20170100369A KR 20170100369 A KR20170100369 A KR 20170100369A KR 1020160022851 A KR1020160022851 A KR 1020160022851A KR 20160022851 A KR20160022851 A KR 20160022851A KR 20170100369 A KR20170100369 A KR 20170100369A
- Authority
- KR
- South Korea
- Prior art keywords
- fraction
- lower leaf
- activity
- composition
- antioxidant
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 34
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 21
- 239000000284 extract Substances 0.000 title claims description 33
- 240000002853 Nelumbo nucifera Species 0.000 title claims description 7
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 15
- 235000006708 antioxidants Nutrition 0.000 title description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 46
- 230000000845 anti-microbial effect Effects 0.000 claims description 28
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 8
- 239000002038 ethyl acetate fraction Substances 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 235000013402 health food Nutrition 0.000 claims description 3
- 230000002292 Radical scavenging effect Effects 0.000 abstract description 20
- 102000003425 Tyrosinase Human genes 0.000 abstract description 19
- 108060008724 Tyrosinase Proteins 0.000 abstract description 19
- 241000588724 Escherichia coli Species 0.000 abstract description 10
- 230000005764 inhibitory process Effects 0.000 abstract description 8
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical class [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 abstract description 4
- 230000008099 melanin synthesis Effects 0.000 abstract description 4
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 28
- 235000019439 ethyl acetate Nutrition 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 13
- 238000002835 absorbance Methods 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 239000002904 solvent Substances 0.000 description 8
- 229940093499 ethyl acetate Drugs 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 240000003768 Solanum lycopersicum Species 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000014171 carbonated beverage Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 235000008960 ketchup Nutrition 0.000 description 3
- 229940041476 lactose 100 mg Drugs 0.000 description 3
- 239000000401 methanolic extract Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000037488 Coccoloba pubescens Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229940022682 acetone Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940043232 butyl acetate Drugs 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940114166 dl dopa Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- KNMNNEPMKDJBDW-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCNC(C)COC1=C(C)C=CC=C1C KNMNNEPMKDJBDW-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008227 sterile water for injection Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 하엽 추출물을 유효성분으로 함유하는 항산화 및 항균 조성물에 관한 것이다.The present invention relates to an antioxidant and antimicrobial composition containing an extract of lower leaves as an active ingredient.
연은 인도와 중국을 중심으로 열대, 온대의 동부아시아를 비롯한 한국, 일본 등에 널리 분포하는 고생대의 식물로 불교에서 신성한 식물로 꽃은 관상용과 차제로 이용하여 왔으며, 잎과 뿌리는 식용하여 왔다. 한방에서 잎은 하엽이라 하며 설사, 두통과 어지러움, 토혈, 산후 어혈치료, 야뇨증, 해독작용에 쓰인다. 그래서 더위와 습기로 인해 설사가 나는 것을 멎게 하고 갈증을 없애주며, 머리와 눈에 쌓인 풍과 열을 맑게 하여 어지럼증을 치료하고, 각혈이나 코피, 뇨혈, 자궁출혈 등의 각종 출혈증의 치료에 좋다.Kite is a paleontic plant widely distributed in tropical and temperate East Asia, Korea and Japan, mainly in India and China. It is a sacred plant in Buddhism. Flowers have been used as ornamental plants and tea plants. Leaves and roots have been edible. In leaves, the leaves are called lower leaves and are used for diarrhea, headache and dizziness, blood clots, postpartum hemorrhage treatment, enuresis, and detoxification. So it stops the diarrhea and stops the diarrhea by heat and moisture, clears the thirst, clears the wind and heat accumulated in the head and eyes, treats dizziness, and is good for the treatment of various hemorrhages such as blood, nosebleeds, uterine bleeding .
한방 문헌에 보면 연잎은 해독작용이 있어 바닷게를 먹고 중독된 경우에 좋다고 나와 있다. 그밖에 연잎 중에서 둥글고 큰 잎을 '부용(芙蓉)'이라고 하는데, 부용은 미녀를 상징하는 것으로 잎이 깨끗하기도 하지만 피부 미용에도 좋기 때문이다. 연잎은 항균작용과 혈압강하 작용을 하며 위장을 튼튼하게 하고 미용과 정력에도 도움을 준다고 한다. 최근에는 연잎을 이용하여 차를 만들기도 하고 잎에 싸서 밥을 하기도 한다. 그러나 하엽의 다양한 생리활성 연구에도 불구하고, 하엽의 항균활성, 항산화효과, 미백활성에 대한 연구보고는 미흡한 실정이다. In the oriental literature, it is said that the lotus leaf has a detoxifying effect and is good when it is poisoned by eating sea bream. In addition, the round and large leaf in the lotus leaf is called "buyon (芙蓉)", and the bouquet is a symbol of beauty and leaves are clean, but it is good for skin beauty. Yeonbyeong has antimicrobial and hypotensive effects, strengthens the stomach, and helps with beauty and vitality. In recent years, tea leaves are used to make tea using leaves. In spite of various studies on the physiological activities of the lower leaves, however, the research on the antimicrobial activity, antioxidative activity and whitening activity of the lower leaves is insufficient.
한편 국내공개특허 2009-0021644호 및 2014-0015662호에서는 하엽 추출물은 대사질환과 관련된 약리효과에 초점을 맞추어 연구가 진행되고 있다. 상기와 같이 하엽 추출물은 약용식물로 널리 시판되었음에도 불구하고, 항산화 및 항균에 대한 예방 및 치료에 대한 효과는 확인되지 못했다.On the other hand, in Korean Patent Laid-Open Nos. 2009-0021644 and 2014-0015662, studies on the pharmacological effects related to metabolic diseases have been carried out on the lower leaves extract. As described above, although the lower leaf extract was widely marketed as a medicinal plant, the effect on prevention and treatment of antioxidant and antibacterial activity was not confirmed.
본 발명자들은 하엽으로부터 다양한 유기용매 분획을 조제하여, 이들의 항산화, 항균 및 미백 활성을 평가한 결과, 하엽의 에틸 아세테이트 분획물에서 우수한 활성을 확인하였다.The present inventors prepared various organic solvent fractions from the lower leaves and evaluated their antioxidant, antibacterial and whitening activity, and found excellent activity in the lower ethyl acetate fraction.
이에, 본 발명의 목적은 하엽 추출물을 유효성분으로 함유하는 항산화 및 항균 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide an antioxidant and antimicrobial composition containing an extract of a lower leaf as an active ingredient.
또한, 본 발명의 다른 목적은 하엽 추출물을 유효성분으로 함유하는, 항산화 및 항균 활성을 가진 건강식품 조성물을 제공하는 것이다.Another object of the present invention is to provide a health food composition having an antioxidant and antimicrobial activity, which contains a lower leaf extract as an active ingredient.
아울러, 본 발명의 또 다른 목적은 하엽 추출물을 유효성분으로 함유하는, 항산화 및 항균 활성을 가진 화장료 조성물을 제공하는 것이다.Yet another object of the present invention is to provide a cosmetic composition having antioxidant and antimicrobial activity, which contains a lower leaf extract as an active ingredient.
그러나 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the technical problem to be solved by the present invention is not limited to the above-mentioned problems, and other matters not mentioned can be clearly understood by those skilled in the art from the following description.
상기와 같은 본 발명의 목적을 달성하기 위하여, 본 발명은 하엽 분획물을 유효성분으로 함유하는 항산화 및 항균용 약학적 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a pharmaceutical composition for antioxidant and antimicrobial containing a lower leaf fraction as an active ingredient.
또한, 본 발명은 하엽 분획물을 유효성분으로 함유하는, 항산화 및 항균용 건강식품 조성물을 제공한다. In addition, the present invention provides a health food composition for antioxidant and antimicrobial containing a lower leaf fraction as an active ingredient.
아울러, 본 발명은 하엽 분획물을 유효성분으로 함유하는, 항산화 및 항균용 화장료 조성물을 제공한다.In addition, the present invention provides an antioxidant and antimicrobial cosmetic composition comprising a lower leaf fraction as an active ingredient.
본 발명에 따른 하엽 (Nelumbo nucifera GAERTNER) 추출물은 특히 에틸아세테이트 분획물에서 DDPH radical 소거활성, ABTS radical 소거활성을 보여 항산화 효과가 우수하다.The extract of Nerumbo nucifera GAERTNER according to the present invention exhibits DDPH radical scavenging activity and ABTS radical scavenging activity especially in the ethyl acetate fraction, showing excellent antioxidative effect.
또한 대장균에 대하여 항균 활성이 있다는 것이 확인되었고, Tyrosinase의 활성을 억제하여 멜라닌 합성을 억제한다는 것이 확인되어, 항산화, 항균, 및 미백 효과가 있는 다용도의 조성물로 사용될 수 있다.It has also been confirmed that it has antimicrobial activity against E. coli and inhibits the activity of tyrosinase to inhibit melanin synthesis and can be used as a multi-purpose composition having antioxidant, antibacterial and whitening effect.
도 1은 하엽의 분획물에 따른 농도별 DPPH radical 소거활성 측정 결과를 나타낸 도면이다.
도 2는 하엽의 분획물에 따른 농도별 ABTS radical 소거활성 결과를 나타낸 도면이다.
도 3은 하엽 분획물의 농도에 따른 Tyrosinase 활성 억제율 측정 결과를 나타낸 도면이다.FIG. 1 is a graph showing the results of measurement of DPPH radical scavenging activity by concentration according to fractions of lower leaves.
FIG. 2 is a graph showing the results of ABTS radical scavenging activity according to concentration according to fractions of the lower leaf.
FIG. 3 is a graph showing the results of measuring the inhibition rate of tyrosinase activity according to the concentration of the lower leaf fraction.
본 발명은 하엽 추출물을 유효성분으로 함유하는 항산화 및 항균용 약학적 조성물을 제공한다. 상기 조성물은 식품 조성물 및 화장료 조성물을 포함한다.The present invention provides a pharmaceutical composition for antioxidant and antimicrobial containing an extract of lower leaves as an active ingredient. The composition comprises a food composition and a cosmetic composition.
이하, 본 발명에 대해 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 식품으로 애용되고 있는 하엽의 부가적인 생리활성 탐색을 위해 건조 하엽으로부터 메탄올 추출물을 조제하고, 이로부터 에틸아세테이트, 부탄올의 다양한 유기용매 분획물 및 물 잔류물을 조제하여 항산화 효과와 항균효과, 멜라닌 합성을 저해하는 Tyrosinase 활성 억제 효과를 알아보기 위해 각각의 활성을 평가하였다.The present invention relates to a method for preparing a methanol extract from a dry lower leaf for preparing an additional physiological activity of a lower leaf which is used as a food, preparing various organic solvent fractions and water residues of ethyl acetate and butanol, In order to investigate the inhibitory effect of tyrosinase activity which inhibits melanin synthesis, each activity was evaluated.
항산화효과의 경우, 에틸 아세테이트에서 가장 우수한 활성이 나타났으며 하엽 분획물의 항균력을 조사한 결과, 500μL/mL 이상의 농도에서 뚜렷한 항균활성을 보였다. S. aureus에 대한 각 시료의 항균력은 n-BuOH > EtOAc > Water 순이며, E.coli에 대한 각 시료의 항균력은 나타나지 않았다. 10, 50, 100 ppm의 농도로 각각 처리하여 tyrosinase 활성을 측정한 결과 농도 의존적으로 tyrosinase 활성 억제율이 컸음을 관찰하였다.The antioxidative activity of ethyl acetate showed the highest activity. The antimicrobial activity of the lower leaf fraction was significantly higher than 500 μL / mL. The antimicrobial activity of each sample against S. aureus was in the order of n-BuOH>EtOAc> Water, and the antibacterial activity of each sample against E. coli was not observed. 10, 50, and 100 ppm, respectively, and tyrosinase activity was measured. As a result, it was observed that the inhibition rate of tyrosinase activity was increased in a concentration dependent manner.
본 발명의 하엽 추출물은 당업계에 공지된 통상의 방법, 즉, 통상적인 온도와 압력의 조건하에서, 통상적인 용매를 사용하여 제조될 수 있다. 본 발명의 하엽 추출물 제조에 사용될 수 있는 추출용매로는 예를 들면, 물, 탄소수 1-6개의 알코올, 아세톤, 에틸아세테이트, 부틸아세테이트 및 1,3 부틸렌 글리콜 등의 추출용매를 단독으로 또는 혼합하여 사용 가능하며, 바람직하게는 메탄올이지만, 이에 제한되는 것은 아니다. 상기 추출 용매의 적합한 양은 하엽 건조 중량의 1 내지 10배 정도이며, 더욱 바람직하게는 5 내지 8배이며, 가장 바람직하게는 5배이다. 또한, 추출방법으로는 열 추출, 냉침 추출, 환류 냉각 추출 및 초음파 추출 등을 사용할 수 있으며, 1회 또는 다수회 반복하여 추출시켜 사용할 수 있다. 또한, 추출온도는 하엽 유용성분의 유효활성이 제거되지 않을 정도의 온도이면, 특별히 제한되지 않으나, 바람직하게는 상온에서 침적시켜 추출한다.The lower leaf extract of the present invention can be prepared using conventional solvents known in the art, that is, under the conditions of ordinary temperature and pressure, using conventional solvents. Examples of the extraction solvent that can be used in the preparation of the lower leaf extract of the present invention include water, an alcohol having 1 to 6 carbon atoms, acetone, ethyl acetate, butyl acetate, 1,3-butylene glycol, etc., , Preferably methanol, but is not limited thereto. The suitable amount of the extraction solvent is about 1 to 10 times, more preferably 5 to 8 times, and most preferably 5 times the dry weight of the lower leaf. As the extraction method, it is possible to use heat extraction, cold extraction, reflux cooling extraction, ultrasonic extraction and the like, and they can be extracted once or repeatedly. The extraction temperature is not particularly limited so long as the effective activity of the useful component of the lower leaf is not removed, but is preferably extracted by immersion at room temperature.
상기 추출물은 메탄올 추출물인 것이 바람직하며, 상기 메탄올 추출물로부터 ethylacetate, n-Butanol 및 수층의 용매별로 순차 분획할 수 있고, 상기 분획물 중에 에틸아세테이트의 항산화 활성 및 항균 활성이 가장 우수하다는 것을 확인하였다.It is preferable that the extract is a methanol extract, and it can be sequentially fractionated from the methanol extract by ethylacetate, n-butanol and water-solvent, and it is confirmed that the fraction has the best antioxidative and antimicrobial activities of ethyl acetate.
본 발명의 조성물은 하엽 추출물과 함께 항산화 활성을 갖는 공지의 유효성분을 1종 이상 함유할 수 있다.The composition of the present invention may contain at least one known active ingredient having antioxidative activity together with the lower leaf extract.
본 발명의 조성물은 항산화 효과 및 항균 효과의 증진을 목적으로 건강기능식품에 첨가될 수 있다. 본 발명의 하엽 추출물을 식품 첨가물로 사용할 경우, 상기 하엽 추출물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용할 수 있고, 통상적인 방법에 따라 적절하게 사용할 수 있다. 유효성분의 혼합양은 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 식품 또는 음료의 제조시 본 발명의 하엽 추출물은 원료에 대하여 15 중량% 이하, 바람직하게는 10 중량% 이하의 양으로 첨가된다. 그러나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용될 수 있다.The composition of the present invention may be added to a health functional food for the purpose of enhancing antioxidative and antimicrobial effects. When the lower leaf extract of the present invention is used as a food additive, the lower leaf extract may be added as it is or may be used together with other food or food ingredients, and may be suitably used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to the intended use (prevention, health or therapeutic treatment). Generally, the lower leaf extract of the present invention is added in an amount of not more than 15% by weight, preferably not more than 10% by weight based on the raw material. However, in the case of long-term intake for the purpose of health and hygiene or for the purpose of health control, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount exceeding the above range.
상기 식품의 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강기능식품을 모두 포함한다.There is no particular limitation on the kind of the food. Examples of the food to which the above substances can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, other noodles, gums, ice cream, various soups, drinks, tea, Alcoholic beverages, and vitamin complexes, all of which include health functional foods in a conventional sense.
본 발명의 건강음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당 및 과당과 같은 모노사카라이드, 말토오스 및 수크로오스와 같은 디사카라이드, 덱스트린 및 시클로덱스트린과 같은 폴리사카라이드, 및 자일리톨, 소르비톨 및 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100㎖당 일반적으로 약 0.01-0.20g, 바람직하게는 약 0.04-0.10g 이다.The health beverage composition of the present invention may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages. The above-mentioned natural carbohydrates are monosaccharides such as glucose and fructose, polysaccharides such as disaccharides such as maltose and sucrose, dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The ratio of the natural carbohydrate is generally about 0.01-0.20 g, preferably about 0.04-0.10 g, per 100 ml of the composition of the present invention.
상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 조성물은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0.01-0.20 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the composition of the present invention may further contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acids and salts thereof, alginic acid and its salts, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, A carbonating agent used in a carbonated beverage, and the like. In addition, the composition of the present invention may contain flesh for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components may be used independently or in combination. The proportion of such additives is not critical, but is generally selected in the range of 0.01-0.20 parts by weight per 100 parts by weight of the composition of the present invention.
아울러, 본 발명은 하엽 분획물을 포함하는 항산화, 항균, 및 미백용 화장료 조성물을 제공할 수 있다.In addition, the present invention can provide antioxidant, antibacterial, and whitening cosmetic compositions containing lower leaf fractions.
상기 화장료 조성물의 제형은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스쳐 크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 또는 바디클렌저의 형태일 수 있다.The formulation of the cosmetic composition may be at least one selected from the group consisting of a skin lotion, a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrition lotion, a massage cream, a nutrition cream, a moisturizer cream, a hand cream, a foundation, , A cleansing foam, a cleansing lotion, a cleansing cream, a body lotion or a body cleanser.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are provided only for the purpose of easier understanding of the present invention, and the present invention is not limited by the examples.
[실시예][Example]
실험방법Experimental Method
재료material
본 실험에서 사용된 하엽(Nelumbo nucifera GAERTNER)은 경북 영천시 화산면에 있는 연근 밭에서 직접 잎을 채취하여 건조한 후 분쇄하여 사용하였다. 추출용매로는 70% 에탄올을 사용하였다. 하엽 300g을 추출용매 3000mL에 혼합하여 25℃에서 24시간씩 3회 반복하여 추출하였다. 추출 후 Whatman No.1로 여과하여 회전감압농축기 (EYELA, Japan)에서 농축하여 ethanol을 제거한 후 그 추출물을 다시 ethylacetate, n-Butanol 및 수층의 용매별로 순차 분획하고, 각 분획층을 감압 농축한 후 농축한 분획물을 DMSO에 일정 농도로 녹인 후 실험에 사용하였다.The lower leaves (Nelumbo nucifera GAERTNER) used in this experiment were directly harvested from the lotus field in the Hwasan area, Yeongcheon, Kyungbuk province, dried, and pulverized. 70% ethanol was used as the extraction solvent. 300 g of lower leaf was mixed with 3000 mL of extraction solvent and extracted three times at 25 캜 for 24 hours. After extracting, it was filtered with Whatman No.1, concentrated by rotary evaporator (EYELA, Japan) to remove ethanol, and then the extract was fractionated by ethylacetate, n- Butanol and water solvent, and each fraction was concentrated under reduced pressure The concentrated fractions were dissolved in DMSO at a certain concentration and used in the experiment.
1) 하엽 추출물의 항산화 활성 방법1) Antioxidant activity of lower leaves extract
(1) DPPH radical 소거활성(1) DPPH radical scavenging activity
DPPH(a,a-diphenyl-β-picrylhydrazyl) radical 소거활성은 Blois(5)등의 방법을 변형하여 측정하였다. 하엽 분획물을 각각 DMSO (dimethylsulfoxide)에 일정농도로 녹인 후 100, 200, 500, 1000, 2000 ppm 농도별로 준비하여 각 sample 100μL에 2M DPPH 용액 100μL 을 넣어 10초간 잘 혼합한 후, 상온에서 30분간 방치한다. 그리고 파장525nm에서 UV/VIS spectrophotometer를 사용하여 흡광도를 측정하였다. DPPH radical 제거능은 시료용액의 첨가구와 무첨가구 사이의 흡광도의 차이를 백분율로 나타내었다.DPPH (a, a-diphenyl-β-picrylhydrazyl) radical scavenging activity was measured by modified Blois (5). The lower leaf fractions were dissolved in dimethylsulfoxide (DMSO) at concentrations of 100, 200, 500, 1000 and 2000 ppm, respectively. M DPPH solution, mix well for 10 seconds, and allow to stand at room temperature for 30 minutes. The absorbance was measured using a UV / VIS spectrophotometer at a wavelength of 525 nm. DPPH radical scavenging ability was expressed as a percentage difference between the absorbance of the sample solution and that of the sample solution.
DPPH radical scavenging acitivity(%)=(1-(Atest-Ablank/Bcontrol))ㅧ100DPPH radical scavenging acitivity (%) = (1- (A test -A blank / B control )) 100
Atest : 시료 첨가구의 흡광도A test : absorbance of sample added sphere
Ablank : blank의 흡광도A blank : absorbance of blank
Bcontrol : 시료 무첨가구의 흡광도B control : absorbance of sample without added sample
2) ABTS radical 소거활성 2) ABTS radical scavenging activity
ABTS(2,2-azino-bis-3-ethylbonzo-thiazoline-6-sulfonic acid)에 의한 항산화능 측정은 Re (5)등의 방법에 따라 측정하였다. ABTS를 7mM 농도로 증류수에 용해한 다음 2.4 mM의 potassium persulfate를 가하여 ABTS radical을 생성시키기 위해 실온의 암소에서 20~24시간 동안 방치하였다. radical이 생성된 ABTS 용액을 94% ethanol로 희석하여 700nm에서 흡광도가 0.700.02가 되도록 조정하였다. 소거능은 ABTS 용액 100μL와 100, 200, 500, 1000, 2000 ppm 농도별 하엽 분획물 100μL를 혼합하여 6분간 반응 후, 파장 700nm에서 흡광도를 측정하였다. ABTS radical 제거능은 시료 용액의 첨가구와 무첨가구 사이의 흡광도의 차이를 백분율로 나타냈다.The antioxidant activity of ABTS (2,2-azino-bis-3-ethylbonzo-thiazoline-6-sulfonic acid) was measured by Re (5). ABTS was dissolved in distilled water at a concentration of 7 mM, and 2.4 mM potassium persulfate was added thereto to allow the formation of ABTS radicals. The incubation was carried out at room temperature for 20 to 24 hours. Radical ABTS solution was diluted with 94% ethanol and absorbance at 700nm was 0.70 0.02. 100 μL of ABTS solution and 100 μL of lower leaf fraction at 100, 200, 500, 1000, 2000 ppm concentrations were mixed for 6 minutes and absorbance was measured at a wavelength of 700 nm. ABTS radical removability was expressed as a percentage of absorbance difference between the addition of the sample solution and no addition.
ABTS radical scavenging acitivity(%)=(1-(Atest-Ablank)/ Bcontrol))ㅧ100ABTS radical scavenging acitivity (%) = (1- (A test -A blank ) / B control )) 100
Atest : 시료 첨가구의 흡광도A test : absorbance of sample added sphere
Ablank : blank의 흡광도A blank : absorbance of blank
Bcontrol : 시료 무첨가구의 흡광도B control : absorbance of sample without added sample
3) 항균 효과3) Antibacterial effect
(1) 사용 균주 (1) Strain used
식중독의 원인균 중에서 그램 양성균 Escherichia coli (E. coli)균 및 Staphylococcus aureus 총 2종을 한국생명공학연구원 생물자원센터 ( Korea Biological Resource Center , KCTC)로부터 구입하여 사용하였다. 실험에 사용한 각 미생물 균주의 균종과 번호는 상기 표 1과 같다.Among the causative organisms of food poisoning, two gram - positive Escherichia coli (E. coli) and Staphylococcus aureus were purchased from the Korea Biological Resource Center (KCTC). The species and number of each microorganism strain used in the experiment are shown in Table 1 above.
균주들의 배양액을 121℃에서 30분간 autoclave에서 멸균한 후 25℃까지 냉각하고 균체는 동결 건조된 균을 loop를 사용하여 고체 배지에 도말한 후 30℃ Incubator(SANYO, Japan)에서 24시간 동안 배양하였다. 그리고 250mL 삼각플라스크에 액체 배지 100mL를 넣고 멸균시킨 후 고체 배지에서 자란 균의 단일 colony를 취해서 액체 배지에 넣어 30℃ shaking Incubator에서 24시간 동안 배양하였다.The cultures of the strains were sterilized in an autoclave at 121 ° C for 30 minutes and then cooled to 25 ° C. The cells were lyophilized using a loop in a solid medium and cultured in Incubator (SANYO, Japan) for 24 hours . Then, 100 mL of the liquid medium was placed in a 250 mL Erlenmeyer flask, sterilized, and then a single colony of the bacteria grown in the solid medium was taken and incubated in a liquid medium for 24 hours in a shaking incubator at 30 ° C.
(2) 항균 효과 (2) Antibacterial effect
각 시료의 항균효과는 E. coli, S. aureus를 대상으로 결과의 정확도가 높고 오염률이 낮은 고체배지를 이용한 Disc paper method로 측정하였다. 도말 평판배지는 계대 배양된 각 균주를 멸균 spread stick을 이용하여 1mL씩 도말하여 준비하였고, 시료를 각 disc당 10mg이 되도록 멸균한 핀셋으로 8mm disc paper (ADVANTEC, Japan)에 흡수시켜 건조시켰다. 건조과정을 거쳐 평판배지 위에 밀착시킨 상태로 37℃의 Incubator(SANYO, Japan)에서 24시간 배양하여 disc 주변에 생성된 clear zone을 측정하여 비교하였다.The antimicrobial activity of each sample was measured by the Disc paper method using E.coli and S. aureus using a solid medium with a high accuracy and a low contamination rate. Each of the subculture strains was prepared by laminating 1 mL each of the subcultured strains using a sterile spread stick. The samples were absorbed in 8 mm disc paper (ADVANTEC, Japan) with sterilized tweezers to 10 mg per disc and dried. Dried and cultured in Incubator (SANYO, Japan) at 37 ° C for 24 hours in a state in which they were in close contact with each other on the plate.
3)Tyrosinase 활성 측정3) Measurement of tyrosinase activity
Tyrosinase 활성 측정은 Tyrosinase의 작용 결과 생성되는 DL-β-3,4-dihydroxypheyl alanine(DOPA) chrome을 비색법에 의해 측정하는 Masanoto등(1)의 방법을 변형하여 실험하였다. Melanin 형성 효소인 TyrosinaTyrosinase activity was measured by modifying the method of Masanoto et al. (1), which measures DL-β-3,4-dihydroxypheyl alanine (DOPA) chrome produced by the action of tyrosinase by colorimetry. Tyrosina, a melanin-forming enzyme
se에 작용해 멜라닌 색소의 생산을 억제하고, 피부에서 활성산소종 생성을 억제하는 효과를 검증하기 위하여 하엽 분획물의 Tyrosinase에 대한 활성을 측정하였다. Tyrosinase 활성도는 96well을 사용하여 측정하였으며, DL-DOPA solution 170μL, PhoIn order to inhibit the production of melanin pigment and to inhibit the production of reactive oxygen species in the skin, the activity of tyrosinase of the lower leaf fraction was measured. The tyrosinase activity was measured using 96 wells, and 170 μL of DL-DOPA solution,
spate buffer 10μL 및 시료용액 10μL에 Tyrosinase 20μL를 첨가하여 35℃에서 20분간 반응시킨 다음 490nm에서 흡광도를 측정하고 아래 식에 따라 Tyrosinase 저해율을 산출하였다.20 μL of tyrosinase was added to 10 μL of spate buffer and 10 μL of sample solution. After reacting at 35 ° C. for 20 minutes, the absorbance was measured at 490 nm and Tyrosinase inhibition rate was calculated according to the following equation.
실험결과Experiment result
1) 하엽 분획물의 항산화 활성1) Antioxidant activity of lower leaves fraction
(1) DPPH radical 소거활성(1) DPPH radical scavenging activity
DPPH radical은 phenol acid 와 flavonoids 및 기타 phenol성 물질에 대한 항산화 작용의 지표인 전자공여능 측정에 이용되는 간편하고 신뢰성 높은 방법으로, 전자 공여할 수 있는 항산화 물질과 반응하게 되면 본래의 자색이 엷어지는 특성이 있다. DPPH radical is a simple and reliable method for measuring electron donating ability which is an index of antioxidative activity against phenol acid, flavonoids and other phenol substances. When DPPH radical reacts with electron donating antioxidants, .
하엽의 분획물에 따른 농도별 DPPH radical 소거활성 측정 결과를 도 1에 나타내었다.Fig. 1 shows the measurement results of DPPH radical scavenging activity by concentration according to fractions of lower leaves.
도 1에서 확인할 수 있는 것과 같이, Water의 경우 대체로 낮은 라디컬 소거능을 나타내었으나 n-BuOH와 EtOAc의 경우 높은 라디컬 소거능을 나타내었다. n-BuOH와 EtOAc는 2000ppm에서 각각 56%와 75%를 나타내었다.As can be seen in FIG. 1, water generally exhibited a low radical scavenging ability, while n- BuOH and EtOAc showed high radical scavenging ability. n- BuOH and EtOAc showed 56% and 75% at 2000 ppm, respectively.
(2) ABTS radical 소거활성(2) ABTS radical scavenging activity
ABTS radical 소거활성은 비교적 안정한 free radical로써 DPPH radical 소거활성과 상관관계가 높으며, 시료 중의 폴리페놀 등의 항산화성 물질과 반응하여 특유의 청록색이 탈색되는 원리로 항산화 활성을 측정하는데 많이 이용되고 있다. ABTS radical scavenging activity is a relatively stable free radical, which is highly correlated with DPPH radical scavenging activity. It is used to measure antioxidative activity by the decolorization of unique cyan color by reacting with antioxidative substances such as polyphenols in the sample.
하엽의 분획물에 따른 농도별 ABTS radical 소거활성 결과를 도 2에 나타내었다.Fig. 2 shows the results of ABTS radical scavenging activity by concentration according to the fraction of lower leaves.
ABTS 또한 water의 경우 대체로 낮은 효과를 나타내었고 EtOAc와 n-BuOH는 높은 효과를 나타내었다. EtOAc와 n-BuOH의 경우 2000PPM과 1000PPM 에서 각각 EtOAc는 99.5%와 98.4%를 n-BuOH는 99.9%와 94.5%를 나타내었다. 대조군인 BHA가 1000ppm에서 94%인 것에 비교하여 EtOAc와 n-BuOH의 활성이 높다는 것을 알 수 있다.ABTS also showed low effect in water and EtOAc and n - BuOH showed high effect. For EtOAc and n- BuOH, 99.5% and 98.4% of EtOAc and 99.9% and 94.5% of n- BuOH were respectively present at 2000PPM and 1000PPM, respectively. It can be seen that the activity of EtOAc and n- BuOH is higher than that of the control BHA of 94% at 1000 ppm.
2) 하엽 분획물의 항균 효과2) The antimicrobial effect of the lower leaves fraction
E. coli, S. aureus 총 2종을 검정균으로 disk paper method에 의하여 하엽 분획물의 항균력을 검정하였다. 항균 효과는 총 2종의 균에 하엽 분획물을 일정농도 100, 200, 500mg/mL 로 처리하였을 때 형성된 생육저해환의 크기로 측정하였다. 그 결과 E. coli 균주에서 EtOAc층은 500ppm에서 16mm의 항균활성효과를 보였고 n-BuOH층에서는 19mm의 항균활성효과를 보였으며 Water층의 경우 13mm의 항균활성 효과를 보였다. S. aureus균주의 경우에는 전체적으로 항균효과가 확인되지 않았다. E. coli and S. aureus were tested for their antibacterial activity by disk paper method. The antimicrobial activity was measured as the size of growth inhibition ring formed when the lower leaves fraction was treated with 100, 200, 500 mg / As a result, in the E. coli strain, the EtOAc layer showed an antimicrobial activity effect at 500 ppm at 16 mm, an antimicrobial activity effect at 19 mm at the n- BuOH layer, and an antimicrobial activity effect at 13 mm in the water layer. In the case of S. aureus strain, the antibacterial effect was not confirmed as a whole.
본 실시예의 결과로 각각의 균주에 따라 각 분획층별 항균력이 다르게 나타났으며 전반적으로 본 발명의 결과를 관찰해 볼 때 E. coli균주에서는 우수한 항균력을 나타내었다.As a result of this example, the antimicrobial activity of each fraction layer was different according to each strain. Overall, the results of the present invention showed excellent antibacterial activity against E. coli strains.
3)Tyrosinase 활성 측정3) Measurement of tyrosinase activity
본 실시예에서는 하엽 분획물 성분이 멜라닌 합성 억제에 미치는 영향을 조사하기 위하여 tyrosinase의 활성 억제 효과를 in vitro방법으로 측정해 보았다. 각 농도별 sample을 첨가한 후의 tyrosinase 활성억제 효과와 비교 측정한 결과이며 하엽 분획물의 농도가 증가함에 따라 tyrosinase 활성 억제율이 농도 의존적으로 증가하였다. 하엽 분획물의 농도에 따른 Tyrosinase 활성 억제율은 도 3에 나타내었다.In this example, the inhibitory effect of tyrosinase on the inhibition of melanin synthesis was examined by an in vitro method. The inhibition rate of tyrosinase activity was increased as the concentration of lower leaf fraction increased. The inhibition rate of tyrosinase activity according to the concentration of the lower leaf fraction is shown in FIG.
상기 실시예를 통해서 하엽 분획물의 효과를 확인해보았다. 항산화 효과의 경우, 에틸 아세테이트에서 가장 우수한 활성이 나타났으며 하엽 분획물의 항균력을 조사한 결과, 500μL/mL 이상의 농도에서 뚜렷한 항균활성을 보였다. S. aureus에 대한 각 시료의 항균력도 우수하게 나타났다. 또한 10, 50, 100 ppm의 농도로 각각 처리하여 tyrosinase 활성을 측정한 결과 농도 의존적으로 tyrosinase 활성 억제율이 컸음을 관찰하였다.The effect of the lower leaf fraction was confirmed through the above examples. The antioxidative activity of ethyl acetate showed the highest activity. The antimicrobial activity of the lower leaf fraction was significantly higher than 500 μL / mL. The antibacterial activity of each sample against S. aureus was also excellent. In addition, tyrosinase activity was measured by treatment with 10, 50, and 100 ppm, respectively. As a result, it was observed that the inhibition rate of tyrosinase activity was increased in a concentration dependent manner.
하기에 본 발명의 조성물을 위한 제제예를 예시한다.Examples of formulations for the composition of the present invention are illustrated below.
제제예 1 : 약학적 제제의 제조Formulation Example 1: Preparation of pharmaceutical preparations
1. 산제의 제조1. Manufacturing of powder
하엽 추출물 200㎎200 mg of lower leaves
유당 100㎎
상기의 성분을 혼합하고 기밀포에 충진하여 산제를 제조하였다.The above components were mixed and packed in airtight bags to prepare powders.
2. 정제의 제조2. Preparation of tablets
하엽 추출물 200㎎200 mg of lower leaves
옥수수전분 100㎎100 mg of corn starch
유당 100㎎
스테아르산 마그네슘 2㎎Magnesium stearate 2 mg
상기의 성분을 혼합한 후, 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조하였다.After mixing the above components, tablets were prepared by tableting according to a conventional method for producing tablets.
3. 캡슐제의 제조3. Preparation of capsules
하엽 추출물 200㎎200 mg of lower leaves
옥수수전분 100㎎100 mg of corn starch
유당 100㎎
스테아르산 마그네슘 2㎎Magnesium stearate 2 mg
상기의 성분을 혼합한 후, 통상의 캡슐제의 제조방법에 따라서 젤라틴 캡슐에 충전하여 캡슐제를 제조하였다.After mixing the above components, the capsules were filled in gelatin capsules according to the conventional preparation method of capsules.
4. 주사제의 제조4. Preparation of injections
하엽 추출물 200㎎200 mg of lower leaves
만니톨 100㎎100 mg mannitol
Na2HPO412H2O 2㎎Na 2 HPO 4 12 H 2 O 2 mg
주사용 멸균 증류수 적량Sterile sterilized water for injection
통상의 주사제의 제조방법에 따라 1 앰플당(2㎖) 상기의 성분을 혼합하여 주사제를 제조하였다.Injection was prepared by mixing the above components per ampoule (2 mL) according to the usual injection preparation method.
제제예 2 : 식품의 제조Formulation Example 2: Preparation of food
본 발명의 하엽 추출물을 포함하는 식품들을 다음과 같이 제조하였다.Foods containing the lower leaf extract of the present invention were prepared as follows.
1. 조리용 양념의 제조1. Preparation of cooking seasoning
하엽 추출물 20-95 중량%로 건강 증진용 조리용 양념을 제조하였다.The safflower for health promotion was prepared by 20 to 95% by weight of lower leaf extract.
2. 토마토 케찹 및 소스의 제조2. Manufacture of tomato ketchup and sauce
하엽 추출물 0.2-1.0 중량%를 토마토 케찹 또는 소스에 첨가하여 건강 증진용 토마토 케찹 또는 소스를 제조하였다.0.2-1.0 wt.% Of lower leaf extract was added to tomato ketchup or sauce to make healthy tomato ketchup or sauce.
3. 밀가루 식품의 제조3. Manufacture of flour food
하엽 추출물 0.5-5.0 중량%를 밀가루에 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하여 건강 증진용 식품을 제조하였다.0.5-5.0 wt% of lower leaf extract was added to wheat flour, and bread, cake, cookies, crackers and noodles were prepared by using this mixture to prepare foods for health promotion.
4. 스프 및 육즙(gravies)의 제조4. Manufacture of soups and gravies
하엽 추출물 0.1-5.0 중량%를 스프 및 육즙에 첨가하여 건강 증진용 육가공 제품, 면류의 수프 및 육즙을 제조하였다.0.1-5.0 wt.% Of lower leaf extract was added to soups and juices to prepare health promotion meat products, noodle soups and juices.
5. 그라운드 비프(ground beef)의 제조5. Manufacture of ground beef
하엽 추출물 10 중량%를 그라운드 비프에 첨가하여 건강 증진용 그라운드 비프를 제조하였다.10% by weight of lower leaf extract was added to ground beef to prepare ground beef for health promotion.
6. 유제품(dairy products)의 제조6. Manufacture of dairy products
하엽 추출물 5-10 중량%를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.5-10% by weight of lower leaf extract was added to milk, and various dairy products such as butter and ice cream were prepared using the milk.
제제예 3 : 음료의 제조Formulation Example 3: Preparation of beverage
1. 탄산음료의 제조1. Manufacture of carbonated beverages
하엽 추출물 10-15%, 설탕 5-10%, 구연산 0.05-0.3%, 카라멜 0.005-0.02%, 비타민 C 0.1-1%의 첨가물을 혼합하고, 여기에 75-80%의 정제수를 섞어서 시럽을 만들었다. 상기 시럽을 85-98℃에서 20-180초간 살균하여 냉각수와 1:4의 비율로 혼합한 다음 탄산가스를 0.5-0.82%를 주입하여 하엽 추출물을 함유하는 탄산음료를 제조하였다.Syrup was prepared by mixing 10-15% of lower leaf extract, 5-10% of sugar, 0.05-0.3% of citric acid, 0.005-0.02% of caramel and 0.1-1% of vitamin C and 75-80% of purified water . The syrup was sterilized at 85-98 ° C for 20-180 seconds, mixed with cooling water at a ratio of 1: 4, and 0.5-0.82% carbon dioxide gas was injected to prepare a carbonated drink containing the lower leaf extract.
2. 건강음료의 제조2. Manufacture of health drinks
하엽 추출물(고형분 2.5%, 97.16%), 대추 엑기스(65 brix, 2.67%), 과체복합 추출물(고형분 70%, 0.12%), 비타민 C(0.02%), 판톤텐산칼슘 (0.02%), 감초 추출물(고형분 65%, 0.01%)을 균질하게 배합하여 순간 살균을 한 후 이를 유리병, 패트병 등 소포장 용기에 포장하여 건강음료를 제조하였다.(70%, 0.12%), vitamin C (0.02%), calcium pantothenate (0.02%), licorice extract (Solid content: 65%, 0.01%) were uniformly blended, instant sterilized, and packaged in small containers such as glass bottles and plastic bottles to produce health drinks.
3. 야채쥬스의 제조3. Manufacture of vegetable juice
하엽 추출물 0.5g을 토마토 또는 당근 쥬스 1,000㎖에 가하여 건강 증진용 야채쥬스를 제조하였다.Healthy vegetable juice was prepared by adding 0.5g of low - leaf extract to 1,000ml of tomato or carrot juice.
4. 과일쥬스의 제조4. Manufacture of fruit juice
하엽 추출물 0.1g을 사과 또는 포도 쥬스 1,000㎖에 가하여 건강 증진용 과일쥬스를 제조하였다.Healthy fruit juice was prepared by adding 0.1 g of lower leaf extract to 1,000 ml of apple or grape juice.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.It will be understood by those skilled in the art that the foregoing description of the present invention is for illustrative purposes only and that those of ordinary skill in the art can readily understand that various changes and modifications may be made without departing from the spirit or essential characteristics of the present invention. will be. It is therefore to be understood that the above-described embodiments are illustrative in all aspects and not restrictive.
Claims (9)
A pharmaceutical composition for antioxidant and antimicrobial use containing a fraction of Nelumbo nucifera GAERTNER as an active ingredient.
The pharmaceutical composition for antioxidant and antimicrobial activity according to claim 1, wherein the lower leaf fraction is a fraction obtained by sequentially fractionating lower leaf extracts with ethyl acetate, butanol, and water.
The pharmaceutical composition according to claim 2, wherein the lower leaf fraction is an ethyl acetate fraction.
A health food composition for antioxidant and antimicrobial, comprising a fraction of Nelumbo nucifera GAERTNER as an active ingredient.
[Claim 5] The composition according to claim 4, wherein the lower leaf fraction is a fraction obtained by sequentially fractionating lower leaf extracts with ethyl acetate, butanol, and water.
5. The composition of claim 4, wherein the lower leaf fraction is an ethyl acetate fraction.
An antioxidant and antimicrobial cosmetic composition comprising a fraction of Nerumbo nucifera GAERTNER as an active ingredient.
8. The cosmetic composition for antioxidant and antimicrobial activity according to claim 7, wherein the lower leaf fraction is a fraction obtained by sequentially fractionating lower leaf extracts with ethyl acetate, butanol, and water.
8. The cosmetic composition according to claim 7, wherein the lower leaf fraction is an ethyl acetate fraction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160022851A KR20170100369A (en) | 2016-02-25 | 2016-02-25 | Composition comprising nelumbo nucifera gaertner extract for anti-oxidant and anti-bacterial effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160022851A KR20170100369A (en) | 2016-02-25 | 2016-02-25 | Composition comprising nelumbo nucifera gaertner extract for anti-oxidant and anti-bacterial effect |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20170100369A true KR20170100369A (en) | 2017-09-04 |
Family
ID=59924330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160022851A KR20170100369A (en) | 2016-02-25 | 2016-02-25 | Composition comprising nelumbo nucifera gaertner extract for anti-oxidant and anti-bacterial effect |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20170100369A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200134929A (en) * | 2019-05-24 | 2020-12-02 | 이승호 | Cosmetic composition containing complex medicinal herbs extract for skin whitening and anti-wrinkle effect and manufacturing method thereof |
-
2016
- 2016-02-25 KR KR1020160022851A patent/KR20170100369A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200134929A (en) * | 2019-05-24 | 2020-12-02 | 이승호 | Cosmetic composition containing complex medicinal herbs extract for skin whitening and anti-wrinkle effect and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101841181B1 (en) | Toothpaste composition comprising herval extract | |
KR20190079202A (en) | Fermentation method of lactic acid bacteria using citrus fruit and its use | |
KR101432940B1 (en) | Preparation method of phenol compounds with enhanced physiological functionality by plasma treatment | |
KR102306737B1 (en) | Antioxidant food comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
KR101046621B1 (en) | Antimicrobial composition comprising sun-dried salt and koji mulberry extract | |
KR101292837B1 (en) | Composition for skin wrinkle improvement comprising extracts of Junglans mandshurica MAXIM as an active ingredient | |
KR101894807B1 (en) | Antimicrobial composition containing Rosa davurica extract as effective component | |
KR100873180B1 (en) | An antibacterial composition comprising an extract of brown algae | |
KR20120133135A (en) | Composition for Prevention or Treatment of Dental Caries Comprising Extract of Cannabis sativa | |
JP2007332081A (en) | Health-and-cosmetic-functional composition, and food/drink and cosmetic each containing the same | |
KR20120031695A (en) | A composition comprising the extract of diospyros kaki thunb as an active ingredient for preventing and treating inflammatory disease | |
JP2010265215A (en) | Methioninase inhibitor | |
EP2990035B1 (en) | 1,5-anhydro-d-glucitol-containing collagen production accelerator | |
KR102158134B1 (en) | Antibacterial composition comprising an extract of schisandra chinesis | |
KR101855989B1 (en) | Method for producing buckwheat seed extract with increased effective component using water adding solubilizer as extraction solvent and buckwheat seed extract produced by the same | |
KR20170100369A (en) | Composition comprising nelumbo nucifera gaertner extract for anti-oxidant and anti-bacterial effect | |
KR101178228B1 (en) | Deodorants, composition and food products for oral cavity | |
KR102100989B1 (en) | Method for producing inner beauty beverage using Chrysanthemum zawadskii and fermeted Rhus verniciflua | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
KR101498075B1 (en) | Composition and health functional food containing extracts of sorghum bran | |
KR101906245B1 (en) | Cosmetic composition for anti-oxidant and skin whitening effect comprising buckwheat seed extract of specific germination condition as effective component | |
KR101429197B1 (en) | Antibacterial Composition Containing Anthriscus sylvestris Extract | |
JP2012006905A (en) | Composition for skin care | |
KR101315805B1 (en) | Composition for Inhibiting Oral Bacteria comprising the extract of Ixeris dentata | |
KR20170077980A (en) | Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E601 | Decision to refuse application |